| AVELUMAB and CETUXIMAB and mFOLFOXIRI as Initial Therapy for Unresectable Metastatic Colorectal Cancer Patients (NCT04513951) | Gruppo Oncologico del Nord-Ovest | 2020-04-01 |
| An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema (NCT04307381) | Ionis Pharmaceuticals, Inc. | 2020-03-31 |
| Study of Oral Metronidazole on Postoperative Chemotherapy in Colorectal Cancer (NCT04264676) | Shanghai Jiao Tong University School of Medicine | 2020-03-31 |
| Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) (NCT04328961) | University of Washington | 2020-03-31 |
| A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection (NCT04343989) | NYU Langone Health | 2020-03-31 |
| Efficacy of Early Administration of Tocilizumab in COVID-19 Patients (NCT04346355) | Azienda USL Reggio Emilia - IRCCS | 2020-03-31 |
| Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia (NCT04333420) | InflaRx GmbH | 2020-03-31 |
| Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome (NCT04256018) | Stanford University | 2020-03-30 |
| A Phase II Study of Triple-negative Breast Cancer Brain Metastases. (NCT04303988) | Fudan University | 2020-03-30 |
| Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer (NCT04246489) | EMD Serono Research & Development Institute, Inc. | 2020-03-30 |
| Treatment of ARDS With Instilled T3 (NCT04115514) | University of Minnesota | 2020-03-30 |
| Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT04329325) | Memorial Sloan Kettering Cancer Center | 2020-03-30 |
| Advancing Brigatinib Properties in ALK+ NSCLC Patients by Deep Phenotyping (NCT04318938) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-03-30 |
| Adoptive Cell Transfer for the Immunotherapy of COVID-19 in Colombia (NCT04344548) | Universidad Nacional de Colombia | 2020-03-30 |
| Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 (NCT04329832) | Intermountain Health Care, Inc. | 2020-03-30 |
| PK and Safety of SI-722 in IC/BPS (NCT04208087) | Seikagaku Corporation | 2020-03-30 |
| CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) (NCT04331808) | Assistance Publique - Hôpitaux de Paris | 2020-03-30 |
| Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) (NCT04318444) | Columbia University | 2020-03-29 |
| Prevention With Chloroquine in Health Personnel Exposed to Infection With Coronavirus Disease 2019 (COVID-19) (TS-COVID) (NCT04627467) | Fundacion Clinica Valle del Lili | 2020-03-28 |
| The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients (NCT04321616) | Oslo University Hospital | 2020-03-28 |
| Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer (NCT04262869) | Emory University | 2020-03-27 |
| Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant (NCT04317781) | M.D. Anderson Cancer Center | 2020-03-27 |
| Addition of Opaganib to Androgen Antagonists in Patients With mCRPC (NCT04207255) | Medical University of South Carolina | 2020-03-27 |
| TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia (NCT04323657) | TCR2 Therapeutics | 2020-03-27 |
| Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI (NCT04324073) | Assistance Publique - Hôpitaux de Paris | 2020-03-27 |
| Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (NCT04329130) | Sun Yat-sen University | 2020-03-27 |
| Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora (NCT04366089) | Roberto Poscia MD, PhD | 2020-03-26 |
| Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without Tislelizumab (NCT04276493) | BeiGene | 2020-03-26 |
| Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer. (NCT04305834) | City of Hope Medical Center | 2020-03-25 |
| A Phase II Trial of Camrelizumab in Combination With Apatinib and Eribulin in Patients With Advanced TNBC (NCT04303741) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2020-03-25 |
| Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients (NCT04071977) | University of Guadalajara | 2020-03-25 |
| Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine (NCT04189588) | TerSera Therapeutics LLC | 2020-03-25 |
| A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TJ011133 as Monotherapy and in Combination With Azacitidine (AZA) in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) (NCT04202003) | TJ Biopharma Co., Ltd. | 2020-03-25 |
| Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients (NCT04458948) | University of New Mexico | 2020-03-24 |
| Crizotinb or Standard Chemotherapy in Met Exon 14 Skipping Advanced NSCLC (NCT04322578) | Hunan Province Tumor Hospital | 2020-03-24 |
| Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients (NCT04388254) | Cassava Sciences, Inc. | 2020-03-24 |
| Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL (NCT04030195) | Precision BioSciences, Inc. | 2020-03-24 |
| Treatment Of Metastatic Bladder Cancer at the Time Of Biochemical reLApse Following Radical Cystectomy (NCT04138628) | Jørgen Bjerggaard Jensen | 2020-03-24 |
| Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis (NCT04179760) | SCM Lifescience Co., LTD. | 2020-03-24 |
| Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer (NCT04322617) | Hunan Province Tumor Hospital | 2020-03-24 |
| Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms (NCT04282187) | University of Washington | 2020-03-24 |
| A Study to Compare the Efficacy and Safety of Ifosfamide and Etoposide With or Without Lenvatinib in Children, Adolescents and Young Adults With Relapsed and Refractory Osteosarcoma (NCT04154189) | Eisai Inc. | 2020-03-23 |
| Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (NCT04323527) | Fundação de Medicina Tropical Dr. Heitor Vieira Dourado | 2020-03-23 |
| Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment (NCT04353336) | Tanta University | 2020-03-23 |
| Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring (NCT05054296) | M.D. Anderson Cancer Center | 2020-03-23 |
| Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma (NCT04322643) | Case Comprehensive Cancer Center | 2020-03-23 |
| Escin in Patients With Covid-19 Infection (NCT04322344) | University of Catanzaro | 2020-03-23 |
| Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4) (NCT04210245) | NGM Biopharmaceuticals, Inc | 2020-03-23 |
| Hydroxychloroquine in COVID-19 Patients (NCT04394442) | Samah Lutfy | 2020-03-21 |
| Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 (NCT04305457) | Massachusetts General Hospital | 2020-03-21 |
| Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NCT04306393) | Massachusetts General Hospital | 2020-03-21 |
| GPED Regimen for Relapsed/Refractory or Advanced ENKTCL (NCT04405375) | Beijing Tongren Hospital | 2020-03-21 |
| Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment (NCT04308980) | Russian Academy of Medical Sciences | 2020-03-20 |
| GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma (NCT04917250) | Beijing Tongren Hospital | 2020-03-20 |
| A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) (NCT04278820) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-03-20 |
| Midostaurin in MRD (Minimal Residual Disease) Positive Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation (NCT03951961) | University of Jena | 2020-03-20 |
| Pain Control in Dentin Hypersensitivity in Patients With MIH (NCT04268238) | University of Nove de Julho | 2020-03-20 |
| The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection (NCT04360980) | Shahid Beheshti University of Medical Sciences | 2020-03-20 |
| The Efficacy and Safety of Zhigancao Tang Granule for HFpEF of Qi-Yin Dificiency (NCT04317339) | Shanghai University of Traditional Chinese Medicine | 2020-03-20 |
| Evaluation of Response to Use of Intravesical Ozone Gas in Interstitial Cystitis /Bladder Pain Syndrome (NCT04789135) | Anhembi Morumbi University | 2020-03-20 |
| Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (NCT04177797) | Sichuan Cancer Hospital and Research Institute | 2020-03-20 |
| Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions (NCT04198623) | University of California, San Francisco | 2020-03-20 |
| Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NCT04326153) | The First Hospital of Jilin University | 2020-03-20 |
| Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) (NCT04317092) | National Cancer Institute, Naples | 2020-03-19 |
| SR-Exenatide (PT320) to Eveluate Efficacy and Safety in Patients With Early Parkinson's Disease (NCT04269642) | Peptron, Inc. | 2020-03-19 |
| Talabostat and Pembrolizumab for the Treatment of Advanced Solid Cancers (NCT04171219) | M.D. Anderson Cancer Center | 2020-03-19 |
| PTG-300 in Subjects With Hereditary Hemochromatosis (NCT04202965) | Protagonist Therapeutics, Inc. | 2020-03-19 |
| Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence (NCT04013672) | David Peereboom | 2020-03-19 |
| Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001 (NCT04313166) | Collaborative Medicinal Development Pty Limited | 2020-03-19 |
| Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma (NCT04107103) | AHS Cancer Control Alberta | 2020-03-19 |
| Safety of RUTI® Vaccination in MDR-TB Patients (NCT02711735) | Archivel Farma S.L. | 2020-03-18 |
| Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies (NCT04181788) | Pfizer | 2020-03-18 |
| Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 (NCT04315298) | Regeneron Pharmaceuticals | 2020-03-18 |
| Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer (NCT04164082) | National Cancer Institute (NCI) | 2020-03-18 |
| A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis (NCT04304144) | Alexion Pharmaceuticals, Inc. | 2020-03-18 |
| Bintrafusp Alfa and Stereotactic Body Radiation Therapy for the Treatment of Recurrent or Second Primary Head and Neck Squamous Cell Cancer (NCT04220775) | M.D. Anderson Cancer Center | 2020-03-18 |
| Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer (NCT03964337) | Duke University | 2020-03-17 |
| Avelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid Tumors (NCT04266912) | M.D. Anderson Cancer Center | 2020-03-17 |
| Converting HR+ Breast Cancer Into an Individualized Vaccine (NCT03804944) | Weill Medical College of Cornell University | 2020-03-17 |
| Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma (NCT04076579) | University of Michigan Rogel Cancer Center | 2020-03-17 |
| The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans (NCT04233749) | Henry Ford Health System | 2020-03-17 |
| A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma (NCT04251416) | Yale University | 2020-03-17 |
| Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection (NCT04385095) | Synairgen Research Ltd. | 2020-03-16 |
| Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer (NCT03831932) | National Cancer Institute (NCI) | 2020-03-16 |
| Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma (NCT03984357) | Sun Yat-sen University | 2020-03-16 |
| Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver (NCT04175912) | National Cancer Institute (NCI) | 2020-03-16 |
| A Study of Selpercatinib (LY3527723) in Participants With Advanced Solid Tumors Including RET Fusion-positive Solid Tumors, Medullary Thyroid Cancer and Other Tumors With RET Activation (NCT04280081) | Eli Lilly and Company | 2020-03-16 |
| Baricitinib Therapy in COVID-19 (NCT04358614) | Fabrizio Cantini | 2020-03-16 |
| Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA (NCT04247815) | Aclaris Therapeutics, Inc. | 2020-03-16 |
| Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) (NCT04170556) | Fundacion Clinic per a la Recerca Biomédica | 2020-03-16 |
| A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC（SHR-1210-AIN457） (NCT04298320) | Yanqiao Zhang | 2020-03-15 |
| Systemic and Topical Antivirals for Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes (NCT03586284) | University of California, San Francisco | 2020-03-15 |
| Laparoscopic Repair of Cesarean Scar Niche (NCT04307524) | Zagazig University | 2020-03-15 |
| Gemcitabine as Maintenance Treatment for Diffuse Pleural Mesothelioma (NCT07411144) | National Cancer Institute, Egypt | 2020-03-15 |
| The Effect of Cannabidiol in Learning and Memory of Adults (NCT06074172) | Colorado State University | 2020-03-14 |
| First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NCT04358458) | Genmab | 2020-03-13 |
| Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant (NCT04022239) | M.D. Anderson Cancer Center | 2020-03-13 |
| Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma (NCT04172805) | Sun Yat-sen University | 2020-03-13 |
| CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy (NCT04266249) | ECOG-ACRIN Cancer Research Group | 2020-03-13 |
| The Effect of Toothpaste Containing Aloe Vera on Gingivitis (NCT04662385) | Zainab J Abbas | 2020-03-13 |